Beltran AS - Search Results

1

Epigenetic reprogramming of cancer cells via targeted DNA methylation.

Rivenbark AG, Stolzenburg S, Beltran AS, Yuan X, Rots MG, Strahl BD, Blancafort P. Rivenbark AG, et al. Among authors: beltran as. Epigenetics. 2012 Apr;7(4):350-60. doi: 10.4161/epi.19507. Epub 2012 Apr 1. Epigenetics. 2012. PMID: 22419067 Free PMC article.

2

Interrogating genomes with combinatorial artificial transcription factor libraries: asking zinc finger questions.

Beltran A, Liu Y, Parikh S, Temple B, Blancafort P. Beltran A, et al. Assay Drug Dev Technol. 2006 Jun;4(3):317-31. doi: 10.1089/adt.2006.4.317. Assay Drug Dev Technol. 2006. PMID: 16834537 Review.

3

Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors.

Beltran A, Parikh S, Liu Y, Cuevas BD, Johnson GL, Futscher BW, Blancafort P. Beltran A, et al. Oncogene. 2007 Apr 26;26(19):2791-8. doi: 10.1038/sj.onc.1210072. Epub 2006 Oct 23. Oncogene. 2007. PMID: 17057734

4

Rational design, selection and specificity of artificial transcription factors (ATFs): the influence of chromatin in target gene regulation.

Blancafort P, Beltran AS. Blancafort P, et al. Among authors: beltran as. Comb Chem High Throughput Screen. 2008 Feb;11(2):146-58. doi: 10.2174/138620708783744453. Comb Chem High Throughput Screen. 2008. PMID: 18336208 Review.

5

Reprogramming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor.

Beltran AS, Sun X, Lizardi PM, Blancafort P. Beltran AS, et al. Mol Cancer Ther. 2008 May;7(5):1080-90. doi: 10.1158/1535-7163.MCT-07-0526. Mol Cancer Ther. 2008. PMID: 18483297 Free PMC article.

6

Remodeling genomes with artificial transcription factors (ATFs).

Beltran AS, Blancafort P. Beltran AS, et al. Methods Mol Biol. 2010;649:163-82. doi: 10.1007/978-1-60761-753-2_10. Methods Mol Biol. 2010. PMID: 20680834

7

Reactivation of MASPIN in non-small cell lung carcinoma (NSCLC) cells by artificial transcription factors (ATFs).

Beltran AS, Blancafort P. Beltran AS, et al. Epigenetics. 2011 Feb;6(2):224-35. doi: 10.4161/epi.6.2.13700. Epub 2011 Feb 1. Epigenetics. 2011. PMID: 20948306 Free PMC article.

8

Suppression of breast tumor growth and metastasis by an engineered transcription factor.

Beltran AS, Russo A, Lara H, Fan C, Lizardi PM, Blancafort P. Beltran AS, et al. PLoS One. 2011;6(9):e24595. doi: 10.1371/journal.pone.0024595. Epub 2011 Sep 13. PLoS One. 2011. PMID: 21931769 Free PMC article.

9

Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factor.

Beltran AS, Rivenbark AG, Richardson BT, Yuan X, Quian H, Hunt JP, Zimmerman E, Graves LM, Blancafort P. Beltran AS, et al. Breast Cancer Res. 2011 Sep 27;13(5):R94. doi: 10.1186/bcr3019. Breast Cancer Res. 2011. PMID: 21952072 Free PMC article.

10

Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer.

Stolzenburg S, Rots MG, Beltran AS, Rivenbark AG, Yuan X, Qian H, Strahl BD, Blancafort P. Stolzenburg S, et al. Among authors: beltran as. Nucleic Acids Res. 2012 Aug;40(14):6725-40. doi: 10.1093/nar/gks360. Epub 2012 May 4. Nucleic Acids Res. 2012. PMID: 22561374 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page